BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33046735)

  • 1. Transcriptional characterization of conjunctival melanoma identifies the cellular tumor microenvironment and prognostic gene signatures.
    Wolf J; Auw-Haedrich C; Schlecht A; Boneva S; Mittelviefhaus H; Lapp T; Agostini H; Reinhard T; Schlunck G; Lange CAK
    Sci Rep; 2020 Oct; 10(1):17022. PubMed ID: 33046735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional Profiling Identifies Prognostic Gene Signatures for Conjunctival Extranodal Marginal Zone Lymphoma.
    Wolf J; Reinhard T; Hajdu RI; Schlunck G; Auw-Haedrich C; Lange C
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA Expression Profile in Conjunctival Melanoma.
    Larsen AC; Mikkelsen LH; Borup R; Kiss K; Toft PB; von Buchwald C; Coupland SE; Prause JU; Heegaard S
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4205-12. PubMed ID: 27548891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MACE RNA sequencing analysis of conjunctival squamous cell carcinoma and papilloma using formalin-fixed paraffin-embedded tumor tissue.
    Boneva S; Schlecht A; Zhang P; Boehringer D; Lapp T; Mittelviefhaus H; Reinhard T; Auw-Haedrich C; Schlunck G; Wolf J; Lange C
    Sci Rep; 2020 Dec; 10(1):21292. PubMed ID: 33277602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Genetics of Conjunctival Melanoma and Prognostic Value of
    van Poppelen NM; van Ipenburg JA; van den Bosch Q; Vaarwater J; Brands T; Eussen B; Magielsen F; Dubbink HJ; Paridaens D; Brosens E; Naus N; de Klein A; Kiliç E; Verdijk RM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
    Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.
    Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C
    Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
    Qu Y; Zhang S; Zhang Y; Feng X; Wang F
    Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized Therapy.
    Demirci H; Demirci FY; Ciftci S; Elner VM; Wu YM; Ning Y; Chinnaiyan A; Robinson DR
    JAMA Ophthalmol; 2019 Dec; 137(12):1444-1448. PubMed ID: 31647501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF1 mutations in conjunctival melanoma.
    Scholz SL; Cosgarea I; Süßkind D; Murali R; Möller I; Reis H; Leonardelli S; Schilling B; Schimming T; Hadaschik E; Franklin C; Paschen A; Sucker A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Br J Cancer; 2018 May; 118(9):1243-1247. PubMed ID: 29559732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Cellular Microenvironment and Novel Specific Biomarkers in Pterygia Using RNA Sequencing.
    Wolf J; Hajdu RI; Boneva S; Schlecht A; Lapp T; Wacker K; Agostini H; Reinhard T; Auw-Hädrich C; Schlunck G; Lange C
    Front Med (Lausanne); 2021; 8():714458. PubMed ID: 35174178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global microRNA profiling of metastatic conjunctival melanoma.
    Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
    Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and transcriptomic landscape of conjunctival melanoma.
    Cisarova K; Folcher M; El Zaoui I; Pescini-Gobert R; Peter VG; Royer-Bertrand B; Zografos L; Schalenbourg A; Nicolas M; Rimoldi D; Leyvraz S; Riggi N; Moulin AP; Rivolta C
    PLoS Genet; 2020 Dec; 16(12):e1009201. PubMed ID: 33383577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
    Han W; Huang B; Zhao XY; Shen GL
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a conjunctival melanoma cell line CM-AS16, newly-established from a metastatic Han Chinese patient.
    Li Y; Shang Q; Li P; Cao J; Zhu L; Jager MJ; Fan X; Ge S; Jia R
    Exp Eye Res; 2018 Aug; 173():51-63. PubMed ID: 29653142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival melanoma: association of cyclooxygenase-2 tumor expression to prognosis.
    Pinto-Proença R; Santos M; Fonseca C; Fernandes J; Gaspar MF; Proença R
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):989-995. PubMed ID: 29297092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status.
    Cao J; Brouwer NJ; Jordanova ES; Marinkovic M; van Duinen SG; de Waard NE; Ksander BR; Mulder A; Claas FHJ; Heemskerk MHM; Jager MJ
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1005-1015. PubMed ID: 29450544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.